スポンサーリンク
Kansai Rousai Hospital | 論文
- PE-152 Adiponectin Deficiency Suppresses ABCA1 Expression and ApoA-I Synthesis in the Liver(Atherosclerosis, basic(04)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-151 Adiponectin Promotes Cholesterol Efflux from Human Macrophages throuth ABCA1-dependent Pathway(Atherosclerosis, basic(04)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Reply to Letter Regarding Article, "Clinical Significance of High-Molecular Weight Form of Adiponection in Male Patients With Coronary Artery Disease"(Author's Reply)
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
- Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver disease
- Expression of Rab5a in hepatocellular carcinoma : Possible involvement in epidermal growth factor signaling